Edition:
India

Cynata Therapeutics Receives Indicative Non-Binding Proposal From Sumitomo Dainippon Pharma


Friday, 19 Jul 2019 

July 19 (Reuters) - Cynata Therapeutics Ltd ::CONFIRMS RECEIPT OF INDICATIVE NON-BINDING PROPOSAL.DECIDED TO GRANT NON-EXCLUSIVE DUE DILIGENCE ACCESS TO SUMITOMO.DEAL FOR A$2.00 PER SHARE IN CASH.RECEIVED AN INDICATIVE, NON-BINDING AND CONDITIONAL PROPOSAL FROM SUMITOMO DAINIPPON PHARMA.CYNATA'S DISCUSSIONS WITH OTHER PARTIES HAVE CEASED.